Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reata Pharmaceuticals

172.36
+0.0000
Volume:- -
Turnover:- -
Market Cap:6.57B
PE:-72.69
High:172.36
Open:172.36
Low:172.36
Close:172.36
Loading ...
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 10, 2023

Major Issues Report

8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 02, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Major Issues Report

8-K - Current report
Oct 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans